Clinical Trials Browser

Phase 2 × Breast Neoplasms × nintedanib × Clear all

NCT01658462 2026-03-16

VAROCE

Phase 2 Completed

Breast Neoplasms

NCT02389764 2019-07-17

Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)

Phase 2 Terminated

10 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms